Brazil’s Anvisa enacts role as overseer of product information and advertising
This article was originally published in Clinica
Executive Summary
Brazil’s Anvisa has formally become the regulator of the “propaganda and advertising” activities of the healthcare products industry. The changes have come through an amendment of the 2006 act that sets out its responsibilities and activities as regulator of medical devices, pharmaceuticals and other healthcare supplies.